Montevideo · 23–26 February 2027 · International Workshop

M-ONT — Montevideo Workshop on Oligonucleotide Therapeutics

The chemistry, biology, and clinical use of oligonucleotide and RNA therapeutics.

M-ONT is a four-day international workshop in Montevideo, Uruguay (23–26 February 2027) — bringing together leading scientists, clinicians, and industry voices to teach the design, mechanism, and clinical translation of antisense oligonucleotides, siRNAs, aptamers, splice-switching ASOs, and emerging RNA therapeutics.

About M-ONT

A four-day, international workshop on oligo therapeutics.

M-ONT is the Montevideo Workshop in OligoNucleotide and RNA Therapeutics — an intensive, internationally focused workshop covering chemistry, biology, delivery, and clinical translation of oligonucleotide and RNA drugs. The programme combines introductory lectures by the organizing committee with research talks from leading invited speakers, plus poster sessions and case-study discussions on landmark approved therapies.

Chemistry

Backbones, modifications, conjugates

Biology

Mechanisms, targets, delivery

Clinic

From bench to approved therapies

Bioinformatics

In silico predictions and design

At a glance

What to expect.

When

23–26 February 2027

Format

Lectures, research talks, posters

Audience

Graduate students, postdocs, clinicians, industry

Language

English

Confirmed Speakers

An international faculty.

Full speaker list →
Adrián R. Krainer

Adrián R. Krainer

Cold Spring Harbor Laboratory

USAUSA

Laura Sepp-Lorenzino

Laura Sepp-Lorenzino

Intellia Therapeutics

USAUSA

Muthiah Manoharan

Muthiah Manoharan

Alnylam Pharmaceuticals

USAUSA

Frank Slack

Frank Slack

Harvard University

USAUSA

Saumya Das

Saumya Das

Harvard University

USAUSA

Isabel Aznarez

Isabel Aznarez

Stoke Therapeutics

USAUSA

Samir El Andaloussi

Samir El Andaloussi

Karolinska Institutet

SwedenSweden

Annemieke Aartsma-Rus

Annemieke Aartsma-Rus

Leiden University Medical Center

NetherlandsNetherlands

Alberto Kornblihtt

Alberto Kornblihtt

IFIBYNE, UBA-CONICET

ArgentinaArgentina

Federico Ariel

Federico Ariel

APOLO Biotech / IFIBYNE

ArgentinaArgentina

Manuel de la Mata

Manuel de la Mata

IFIBYNE, UBA-CONICET

ArgentinaArgentina

Modesto Orozco

Modesto Orozco

IRB Barcelona

SpainSpain

Macarena Hernández

Macarena Hernández

aptaTargets / Universidad Complutense

SpainSpain

Zoya Ignatova

Zoya Ignatova

Hamburg University

GermanyGermany

Emanuele Buratti

Emanuele Buratti

ICGEB Trieste

ItalyItaly

Rodrigo Galindo-Murillo

Rodrigo Galindo-Murillo

IONIS Pharmaceuticals

USAUSA

?

To be confirmed

?

To be confirmed

Organizing Committee

The people behind M-ONT.

National

Victoria Calzada

Victoria Calzada

Universidad de la República

UruguayUruguay

Juan Pablo Tosar

Juan Pablo Tosar

Institut Pasteur de Montevideo

Universidad de la República

UruguayUruguay

Pablo D. Dans

Pablo D. Dans

Universidad de la República

Institut Pasteur de Montevideo

UruguayUruguay

International

Isabel Aznarez

Isabel Aznarez

Stoke Therapeutics

USAUSA

Alberto Kornblihtt

Alberto Kornblihtt

Universidad de Buenos Aires

ArgentinaArgentina

Adrián R. Krainer

Adrián R. Krainer

Cold Spring Harbor Laboratory

USAUSA

Laura Sepp-Lorenzino

Laura Sepp-Lorenzino

Intellia Therapeutics

USAUSA

Participate

Register, submit an abstract, apply for a fellowship.

All participants must register and are invited to submit abstracts. Selected submissions will be presented in the poster session, and a small number of contributions may be selected for a short talk within the programme. Early career researchers can additionally apply for an ICGEB fellowship covering meals and accommodation.

Registration and abstract submission: 3 August – 30 September 2026, 23:59 Montevideo time (UTC-3).